Full Smile Periodontics · Amarillo, TX · Patient Education

The research is clear and consistent — gum disease is not a condition that stays in your mouth. Its effects extend to your heart, your blood sugar, your bones, your lungs, and beyond. Here is what every patient should understand about the systemic connections that make periodontal health a whole-body issue.

For most of the history of dentistry, the mouth was treated as a system separate from the rest of the body — oral health was oral health, and systemic health was something else entirely. That model has been dismantled decisively by decades of research that reveals the mouth not as an isolated system but as an integrated part of the body's overall biology — one with direct, bidirectional connections to some of the most significant health conditions affecting adults today.

Periodontal disease — gum disease — is a chronic bacterial infection of the structures supporting the teeth. It destroys gum tissue and bone. It is the leading cause of tooth loss in adults. And its effects do not stop at the gum line.

The bacteria driving periodontal infection enter the bloodstream through inflamed, ulcerated gum tissue. The chronic inflammatory response that gum disease sustains circulates mediators throughout the body. The metabolic disruption it creates interacts with conditions including diabetes, cardiovascular disease, osteoporosis, respiratory illness, and adverse pregnancy outcomes in ways that are now well-documented in the research literature.

This is not speculative. It is not fringe science. It is the consensus of major medical and dental organizations who have reviewed the accumulated evidence — and it has meaningful implications for how patients and their care teams should think about gum health.

At Full Smile Periodontics, we see patients whose gum disease has been progressing silently alongside systemic conditions that their medical providers are managing separately — without a connection being made between the two. This guide explains those connections clearly, so that patients can understand why periodontal health is not a narrow dental concern but a genuine component of whole-body health.

Concerned About Your Gum Health in Amarillo?

Full Smile Periodontics provides expert periodontal evaluation and treatment for patients throughout the Texas Panhandle. Schedule your consultation today.

Get Started Call Us: (806) 699-6111

Understanding the Mechanism — How Gum Disease Affects the Rest of the Body

Before exploring each systemic connection specifically, it helps to understand the biological mechanisms through which periodontal disease exerts its effects beyond the mouth. There are three primary pathways.

Bacteremia — Bacteria in the Bloodstream

The gum tissue surrounding the teeth — when healthy — forms a tight seal against the root surface that prevents oral bacteria from entering the bloodstream. In periodontal disease, that seal is broken down. The inflamed, ulcerated pocket tissue that characterizes moderate to advanced periodontitis provides an open pathway for oral bacteria to enter the systemic circulation.

Research has identified periodontal pathogens — the specific bacteria associated with gum disease — in atherosclerotic plaques, in the placenta, in the synovial fluid of arthritic joints, and in other distant body sites where they have no business being. Their presence at these sites is not incidental. It represents bacterial translocation from the oral environment through a compromised periodontal barrier.

Routine activities — chewing, brushing, flossing — produce brief episodes of bacteremia in patients with active periodontal disease. The cumulative effect of repeated bacterial seeding of the bloodstream over months and years of chronic infection is meaningful systemic exposure to oral pathogens.

Systemic Inflammation

The immune response to chronic periodontal infection produces a sustained elevation in pro-inflammatory cytokines — signaling molecules including interleukin-1, interleukin-6, tumor necrosis factor-alpha, and C-reactive protein that circulate systemically and affect distant tissues and organs.

These same inflammatory mediators are central to the pathology of cardiovascular disease, diabetes, arthritis, and numerous other chronic conditions. When periodontal disease adds to the body's overall inflammatory burden, it does not simply create parallel inflammation — it contributes to and amplifies inflammatory processes that are already driving systemic disease.

Elevated C-reactive protein — a widely used marker of systemic inflammation and an independent risk factor for cardiovascular events — is consistently found at higher levels in patients with periodontal disease than in periodontally healthy individuals. Successful periodontal treatment has been shown to reduce C-reactive protein levels, suggesting a direct causal relationship rather than simple correlation.

Insulin Resistance and Metabolic Disruption

Chronic inflammation — of the type sustained by active periodontal disease — promotes insulin resistance at the cellular level. Inflammatory cytokines interfere with insulin signaling pathways, making cells less responsive to insulin and contributing to the glycemic dysregulation that characterizes type 2 diabetes. This mechanism creates a bidirectional relationship between periodontal disease and diabetes that is now among the most studied connections in the oral-systemic research literature.

Gum Disease and Diabetes — A Bidirectional Relationship

The connection between periodontal disease and diabetes is one of the most extensively researched and well-established links in the oral-systemic literature. The relationship runs in both directions — each condition worsens the other — and understanding it has practical implications for the management of both.

How Diabetes Affects Periodontal Disease

Poorly controlled blood sugar — elevated HbA1c — impairs immune function in ways that directly affect the body's ability to fight the bacterial infection driving periodontal disease. Neutrophils — the immune cells that are the first line of defense against bacterial invasion — are less functional in diabetic patients, allowing periodontal pathogens to establish and maintain infection more readily.

Diabetes also causes microvascular changes — damage to the small blood vessels throughout the body — that reduce blood supply to the gum tissue. Gum tissue that is not adequately perfused heals poorly, responds less effectively to treatment, and is more vulnerable to the destructive effects of bacterial infection. The result is that diabetic patients experience more severe periodontal disease, faster disease progression, and poorer response to treatment than non-diabetic patients with equivalent bacterial burden.

How Periodontal Disease Affects Diabetes

The relationship is not one-directional. The chronic inflammation of active periodontal disease promotes insulin resistance through the cytokine mechanisms described above, making blood sugar harder to control in diabetic patients and contributing to the development of type 2 diabetes in patients who are prediabetic or at risk.

Multiple studies have demonstrated that treating periodontal disease in diabetic patients produces measurable improvements in glycemic control — reductions in HbA1c levels comparable in some research to adding a second diabetes medication. The American Diabetes Association has acknowledged the bidirectional relationship between periodontal disease and diabetes and recommends that diabetic patients receive periodontal evaluation as part of their overall diabetes management.

The Clinical Implication

For diabetic patients — and for patients with prediabetes or metabolic syndrome — periodontal health is not a dental side issue. It is a variable in their metabolic control. Poorly controlled periodontal disease makes blood sugar harder to manage. Well-treated periodontal disease removes one of the inflammatory drivers of insulin resistance. Managing both conditions together produces better outcomes than managing either in isolation.

Gum Disease and Cardiovascular Disease — Heart Health and the Oral Connection

The connection between periodontal disease and cardiovascular disease is among the most significant — and most clinically consequential — in the oral-systemic literature. Multiple large-scale epidemiological studies have found that patients with periodontal disease have a significantly elevated risk of cardiovascular events including heart attack and stroke compared to periodontally healthy individuals.

Atherosclerosis and Oral Bacteria

Atherosclerosis — the buildup of plaques within arterial walls that narrows and stiffens the arteries and creates the conditions for heart attack and stroke — has been found to contain oral bacteria, particularly Porphyromonas gingivalis, one of the primary pathogens associated with chronic periodontitis. The presence of these bacteria in arterial plaque is not coincidental — they have been shown to actively promote plaque formation and to activate inflammatory pathways within the arterial wall that accelerate plaque progression.

The mechanism is understood: periodontal bacteria enter the bloodstream through the ulcerated pocket tissue of infected gums, circulate to distant sites including arterial walls, invade the cells lining the arteries, and trigger inflammatory responses that contribute to plaque formation and instability. A plaque that ruptures causes the blood clot formation that produces a heart attack or stroke — and periodontal pathogens have been shown to contribute to plaque instability.

Endocarditis Risk

Infective endocarditis — a serious infection of the inner lining of the heart chambers and valves — can result from bacteremia originating in the oral cavity. Patients with certain cardiac conditions including prosthetic heart valves, a history of endocarditis, and specific congenital heart defects are at elevated risk. This is well-established enough that antibiotic prophylaxis before certain dental procedures is recommended for high-risk cardiac patients by the American Heart Association.

For patients with periodontal disease specifically, the chronic bacteremia associated with inflamed, infected gum tissue represents a sustained cardiac risk that extends well beyond isolated dental procedures.

Systemic Inflammation and Cardiac Risk

Beyond direct bacterial pathways, the elevated systemic inflammation associated with periodontal disease contributes to cardiovascular risk through C-reactive protein elevation, promotion of endothelial dysfunction — damage to the cells lining the blood vessels — and effects on blood coagulation that increase the risk of the clot formation that precipitates cardiac events.

The American Heart Association has acknowledged in a scientific statement that periodontal disease is independently associated with cardiovascular disease and that the biological mechanisms for a causal relationship are plausible and supported by evidence, while calling for further research to fully characterize the nature of the relationship.

Managing a Chronic Condition and Concerned About Your Gum Health?

Periodontal disease and systemic conditions are often managed separately — but they interact directly. Our Amarillo periodontal team works closely with your medical providers to support your whole-body health.

Schedule a Consultation Call Full Smile Periodontics: (806) 699-6111

Gum Disease and Osteoporosis — The Bone Connection

The connection between periodontal disease and osteoporosis is both direct and indirect — and it runs through the same fundamental biology that makes bone health a concern throughout the body in osteoporotic patients.

Shared Bone Loss Mechanisms

Osteoporosis is characterized by systemic reduction in bone density — a loss of mineral content that weakens bone structure throughout the skeleton and increases fracture risk. Periodontal disease causes localized bone loss in the jaw — the progressive destruction of the alveolar bone that supports the teeth — through inflammatory mechanisms driven by the immune response to bacterial infection.

These two processes are distinct in their cause but share important biological pathways. The inflammatory cytokines that drive periodontal bone loss — particularly RANKL and interleukin-1 — are also involved in systemic bone metabolism. In patients with osteoporosis, the systemic reduction in bone density affects the jawbone as well as the rest of the skeleton, potentially making the jaw more vulnerable to the bone-destructive effects of periodontal disease.

Research has found that postmenopausal women with osteoporosis have greater tooth loss and more severe alveolar bone loss than those without osteoporosis. The relationship appears to be synergistic — osteoporosis does not cause periodontal disease, but it may amplify its bone-destructive effects in patients who have both conditions.

Bisphosphonate Medications and Periodontal Considerations

Patients being treated for osteoporosis with bisphosphonate medications — including alendronate (Fosamax), risedronate (Actonel), and intravenous formulations such as zoledronic acid — require specific attention in the context of periodontal treatment. Bisphosphonates affect bone metabolism in ways that can affect healing following periodontal procedures and tooth extractions, and in rare cases are associated with osteonecrosis of the jaw — a condition in which jawbone tissue fails to heal properly following surgery.

For patients on bisphosphonate therapy, full disclosure of medications is essential before any periodontal treatment is undertaken. Our team coordinates with your medical provider to ensure treatment planning accounts for any relevant medication effects. This is not a reason to avoid periodontal treatment — untreated periodontal disease carries its own risks for bone health — but it is a reason for careful, coordinated planning.

Vitamin D, Calcium, and Periodontal Health

Vitamin D and calcium — the nutrients most directly associated with bone health — also play roles in oral health. Vitamin D has anti-inflammatory and immunomodulatory effects that may reduce susceptibility to periodontal inflammation. Low vitamin D levels have been associated in some studies with more severe periodontal disease. Patients being treated for osteoporosis who are receiving calcium and vitamin D supplementation as part of their management may derive some periodontal benefit as well — though supplementation is not a substitute for periodontal treatment when disease is present.

Gum Disease and Pregnancy — Risks to Mother and Baby

The relationship between periodontal disease and adverse pregnancy outcomes is among the most studied oral-systemic connections and has direct implications for pregnant women and those planning pregnancy.

Pregnancy Gingivitis

Hormonal changes during pregnancy — particularly elevated progesterone and estrogen levels — alter the gum tissue's response to bacterial plaque, producing an exaggerated inflammatory response to levels of plaque that would cause minimal inflammation in a non-pregnant patient. Pregnancy gingivitis — gum inflammation during pregnancy — is extremely common and in some studies affects the majority of pregnant women to some degree.

Pregnancy gingivitis is not simply a cosmetic or comfort issue. It is a sign of active gum inflammation that, if not managed, can progress to or worsen existing periodontitis during the pregnancy. The inflammatory and bacterial burden of active gum disease during pregnancy has been associated with systemic effects that extend to pregnancy outcomes.

Preterm Birth and Low Birth Weight

The most clinically significant connection between periodontal disease and pregnancy is the association with preterm birth — delivery before 37 weeks — and low birth weight. Multiple studies have found that pregnant women with moderate to severe periodontal disease have significantly elevated rates of preterm delivery compared to periodontally healthy pregnant women.

The proposed mechanisms include the systemic elevation of prostaglandins — compounds that play a role in triggering labor — by the inflammatory mediators associated with periodontal infection, and the potential for periodontal bacteria to reach the placental and amniotic tissues through bacteremia. Elevated levels of periodontal bacteria have been found in amniotic fluid and in placental tissue samples from women who delivered preterm.

Preeclampsia

Preeclampsia — a serious pregnancy complication characterized by high blood pressure and signs of organ damage — has also been associated with periodontal disease in research studies. The connection is thought to involve the systemic inflammation and endothelial dysfunction associated with chronic periodontal infection contributing to the vascular dysregulation that underlies preeclampsia.

The Clinical Recommendation

Dental care during pregnancy — including periodontal evaluation and treatment of active gum disease — is safe and recommended. The American College of Obstetricians and Gynecologists, the American Dental Association, and major periodontal organizations all support periodontal care during pregnancy as an important component of prenatal health. Women who are planning pregnancy should prioritize a periodontal evaluation before conception when possible — addressing active gum disease before pregnancy begins reduces the risk of progression and systemic effects during the pregnancy itself.

Gum Disease and Respiratory Health — The Lung Connection

The connection between periodontal disease and respiratory conditions — while perhaps less intuitively obvious than the diabetes and cardiovascular connections — is supported by a meaningful body of research, particularly in the context of pneumonia and chronic obstructive pulmonary disease.

Aspiration Pneumonia

Aspiration pneumonia results from the inhalation of oral bacteria into the lungs, where they establish infection in susceptible patients. The oral cavity is the primary reservoir of the bacteria most commonly associated with aspiration pneumonia — and the bacterial load in the oral cavity is dramatically higher in patients with periodontal disease than in periodontally healthy individuals.

In hospitalized patients, elderly patients in long-term care, and patients who are mechanically ventilated, aspiration pneumonia is a serious and in some cases fatal complication. Research has consistently found that improving oral hygiene and reducing the bacterial burden in the mouth — including treating periodontal disease — reduces the incidence of aspiration pneumonia in these populations. This finding has driven widespread adoption of oral hygiene protocols in intensive care units.

Chronic Obstructive Pulmonary Disease

COPD — the umbrella term for chronic bronchitis and emphysema — is characterized by chronic airway inflammation and progressive loss of lung function. Epidemiological studies have found associations between periodontal disease and COPD severity, with periodontal bacteria contributing to the bacterial colonization of the lower airways that is associated with COPD exacerbations. The shared inflammatory mechanisms between periodontal disease and airway inflammation may also contribute to the association.

For patients with existing respiratory conditions — particularly those who are elderly, immunocompromised, or hospitalized — reducing the oral bacterial load through periodontal treatment is a meaningful component of respiratory risk management.

Gum Disease and Alzheimer's Disease — An Emerging Area of Research

The research connecting periodontal disease to cognitive decline and Alzheimer's disease is more recent and less conclusively established than the connections to diabetes and cardiovascular disease, but it is a rapidly growing area of scientific investigation with concerning preliminary findings.

Porphyromonas Gingivalis and the Brain

Porphyromonas gingivalis — the primary bacterial pathogen associated with chronic periodontitis — has been identified in the brain tissue of Alzheimer's patients at autopsy in multiple studies. A landmark study published in the journal Science Advances in 2019 found that P. gingivalis and its toxic enzymes called gingipains were present in the brains of Alzheimer's patients and that in animal models, oral infection with P. gingivalis resulted in brain colonization, increased production of amyloid beta — the protein that forms the plaques characteristic of Alzheimer's — and neural damage.

Systemic Inflammation and Neurodegeneration

Beyond direct bacterial pathways, the chronic systemic inflammation associated with periodontal disease may contribute to neuroinflammation — a process increasingly understood to play a central role in the pathology of Alzheimer's and other neurodegenerative conditions. The same cytokines elevated in periodontal disease are found at elevated levels in the brains of Alzheimer's patients, and systemic inflammation is now recognized as a contributor to neurodegeneration rather than simply a byproduct of it.

The research in this area is active and evolving. The findings to date do not establish that gum disease causes Alzheimer's — the causal relationship has not been fully characterized, and clinical trials examining whether periodontal treatment reduces cognitive decline risk are underway. What the existing evidence does establish is a biologically plausible connection that warrants serious attention, particularly for older patients managing periodontal disease alongside cognitive health concerns.

Gum Disease and Rheumatoid Arthritis

Rheumatoid arthritis — an autoimmune condition in which the immune system attacks the synovial tissue of the joints — shares important biological features with periodontal disease, and the research connecting the two conditions has revealed a relationship that goes beyond coincidence.

Both conditions are characterized by chronic inflammatory destruction of supporting structures — bone and connective tissue in the joints for rheumatoid arthritis, bone and connective tissue around the teeth for periodontal disease. Both involve the same pro-inflammatory cytokines — tumor necrosis factor-alpha, interleukin-1, and interleukin-6 — as primary mediators of tissue destruction.

Porphyromonas gingivalis has attracted particular attention in the context of rheumatoid arthritis because it is uniquely capable of producing citrullinated proteins — proteins modified by an enzyme called PPAD — that are the specific target of the anti-citrullinated protein antibodies used to diagnose rheumatoid arthritis. The hypothesis that P. gingivalis infection in the gum tissue may be a trigger for the autoimmune response in genetically susceptible individuals that leads to rheumatoid arthritis is actively investigated and has significant supporting evidence.

Epidemiological studies have consistently found higher rates of periodontal disease in rheumatoid arthritis patients and greater severity of both conditions when they co-occur. Clinical studies have found improvements in rheumatoid arthritis disease activity markers following periodontal treatment — consistent with the removal of an inflammatory and antigenic source that was contributing to systemic disease activity.

Periodontal Health Is Whole-Body Health — Let Us Help You Protect Both

Full Smile Periodontics provides expert periodontal care in Amarillo, TX. If it has been a while since your gums were evaluated — or if you have been managing a chronic health condition and want to understand the periodontal connection — we are here.

Schedule Your Evaluation Contact Our Office Call Us: (806) 699-6111

What This Means for Your Care — The Integrated Approach

The accumulation of research connecting periodontal disease to systemic health conditions has a practical implication that extends beyond patient education: it argues for a more integrated approach to care in which dental and medical providers communicate, coordinate, and consider each other's domains as genuinely relevant to their own.

For patients with diabetes, cardiovascular disease, osteoporosis, rheumatoid arthritis, or respiratory conditions — or for patients with risk factors for any of these conditions — periodontal health should be a regular, explicit part of the conversation with both their dentist and their physician. A physician managing a diabetic patient's HbA1c who does not know that patient has active periodontal disease is missing a variable that affects the condition they are treating. A periodontist treating a patient's gum disease who does not know that patient is on bisphosphonate therapy is missing a factor that affects the safety of the treatment being planned.

At Full Smile Periodontics, we approach every patient's periodontal care within the context of their full health picture. We communicate with referring and collaborating providers, we ask about systemic conditions and medications, and we develop treatment plans that account for the bidirectional relationships between periodontal health and the conditions our patients are managing. Learn about what to expect at your first visit and how we gather the complete picture needed to provide integrated, informed care.

For dentists and other providers who refer patients to our practice, we welcome collaboration and communication throughout the treatment process. Learn more about our patient referral process.

The Bottom Line — Why Gum Health Matters Beyond Your Smile

The evidence connecting periodontal disease to systemic health is not a reason for alarm — it is a reason for action. The conditions described in this guide are serious, but the preventive and therapeutic message is clear and optimistic: treating and maintaining periodontal health is achievable, and doing so removes one of the modifiable inflammatory and infectious contributors to conditions that affect millions of adults.

Periodontal disease is common — estimates suggest that nearly half of American adults have some form of it, with the prevalence rising significantly in older adults. It is largely preventable with consistent professional care and effective home hygiene. And when it is present, it is treatable — at virtually every stage of its progression. The patients who suffer the most from the systemic consequences of periodontal disease are overwhelmingly the ones whose disease was allowed to progress undetected or untreated for years.

The case for regular periodontal evaluation and prompt treatment of active disease is not simply about preserving teeth. It is about protecting the integrated biological system in which those teeth exist — a system that includes your heart, your metabolic function, your bones, your lungs, your joints, and your brain.

That is why gum health matters beyond your smile. And that is why the team at Full Smile Periodontics approaches every patient's care with the seriousness that systemic stakes deserve.

Frequently Asked Questions

Can treating gum disease actually improve my diabetes control?

Research has consistently found that treating periodontal disease in diabetic patients produces measurable improvements in glycemic control — with some studies finding reductions in HbA1c levels comparable to the effect of adding a diabetes medication. The mechanism is the reduction of the chronic inflammation that promotes insulin resistance. The relationship is bidirectional — better blood sugar control also improves periodontal treatment outcomes. Managing both conditions together produces better results than managing either in isolation. Schedule a consultation to discuss how your periodontal health relates to your overall diabetes management.

Is gum disease actually linked to heart attacks?

Multiple large-scale epidemiological studies have found that patients with periodontal disease have significantly elevated cardiovascular risk compared to periodontally healthy individuals. Periodontal bacteria have been identified in atherosclerotic plaques, and the chronic systemic inflammation associated with gum disease contributes to the endothelial dysfunction and plaque instability that precipitate cardiac events. The American Heart Association has acknowledged the association and the biological plausibility of causal mechanisms, while noting that more research is needed to fully characterize the relationship.

Should I tell my periodontist about my other health conditions?

Absolutely — and this is one of the most important things you can do to ensure safe, effective periodontal care. Conditions including diabetes, cardiovascular disease, osteoporosis, rheumatoid arthritis, and respiratory conditions all have direct relevance to how your gum disease is assessed and treated. Medications — including bisphosphonates, blood thinners, immunosuppressants, and many others — affect treatment planning and healing. Our team asks about your full health history at your first visit precisely because this information shapes the care we provide.

I have been told I have gum disease but I feel fine — does it really matter if I treat it?

Yes — and the absence of symptoms is precisely what makes periodontal disease so consequential when left untreated. Gum disease progresses largely without pain through its early and moderate stages, during which time it is continuously contributing to the systemic inflammatory burden described in this guide. By the time symptoms become obvious, significant damage — to the gums, the supporting bone, and potentially to systemic health — has already occurred. Treating disease that feels fine at the stage when it can be treated most simply and effectively is always the right decision.

Does everyone with gum disease develop these systemic conditions?

No — having periodontal disease does not guarantee that a patient will develop heart disease, diabetes, or the other conditions discussed in this guide. These are associations that increase risk — not deterministic relationships. Many factors contribute to each of these conditions, and periodontal disease is one modifiable risk factor among several. The point is not that gum disease causes all of these conditions in every patient — it is that treating it removes a modifiable contributor to systemic inflammatory burden and reduces risk.

How do I know if I have gum disease?

Gum disease frequently produces no significant symptoms in its early and moderate stages — which is why professional evaluation is the only reliable way to know your periodontal status. Signs that may indicate gum disease include bleeding when brushing or flossing, red or swollen gum tissue, persistent bad breath, gum recession, and in more advanced cases loose or shifting teeth. If you have any of these signs — or if it has been more than a year since your gums were formally evaluated with periodontal probing — schedule a consultation with our team.

I am pregnant — is it safe to have periodontal treatment?

Yes. Periodontal evaluation and treatment of active gum disease during pregnancy is safe and is recommended by major obstetric and dental organizations. The risks of untreated active periodontal disease during pregnancy — including associations with preterm birth and low birth weight — are significantly greater than the risks of appropriate periodontal treatment. If you are pregnant and have concerns about your gum health, please contact our office — we will ensure your care is managed appropriately for your stage of pregnancy.

My dentist referred me to a periodontist — what should I expect?

A referral to a periodontist means your dentist has identified periodontal disease or a periodontal concern that requires the specialized expertise of a periodontal specialist. At Full Smile Periodontics, your first visit involves a comprehensive periodontal evaluation — including pocket depth measurements, assessment of bone levels on X-rays, evaluation of gum tissue health, and a thorough review of your health history. We will explain what we find, what we recommend, and why — clearly and without pressure. Learn more about what to expect at your first visit.

Your Gum Health Is Not Separate From Your Overall Health — It Never Was

The research is clear. The mechanisms are understood. The clinical evidence is consistent across decades of study and across multiple serious systemic conditions. Gum disease is a chronic infection with systemic reach — and treating it is not simply about keeping your teeth. It is about protecting your heart, supporting your metabolic health, preserving your bone density, reducing your risk of adverse pregnancy outcomes, and contributing to the overall inflammatory balance that underlies long-term health.

Full Smile Periodontics provides expert periodontal care for patients throughout Amarillo and the Texas Panhandle — with an approach that treats every patient's gum health within the full context of their systemic health picture. Whether you are a patient managing multiple chronic conditions or someone who simply wants to be proactive about an area of health that has not received enough attention, we are here.

Schedule your evaluation or contact our office to get started. For referring providers, learn about our referral process — we welcome the opportunity to collaborate on behalf of our shared patients.

Take Your Gum Health Seriously — Your Body Will Thank You

Full Smile Periodontics provides specialized periodontal care for patients throughout Amarillo, TX and the Texas Panhandle. New patients and referrals welcome.

Get Started Today Contact Our Office Call Us: (806) 699-6111